Antibody Engineering & Therapeutics Asia Kyoto

Antibody Engineering & Therapeutics Asia is the leading conference in Asia dedicated to therapeutic antibodies and protein-based drugs. As the regional edition of the renowned international Antibody Engineering & Therapeutics event series, it brings together key players from the global biopharmaceutical and biotechnology sectors each year in Kyoto, Japan. The conference is held at The Westin Miyako Kyoto, a venue that combines traditional charm with modern amenities. Organized by Informa Connect, a division of Informa PLC, the event is known for its scientific excellence and thematic depth, offering an outstanding platform for expert exchange.

At its core, the conference covers the entire development lifecycle of therapeutic antibodies – from early discovery to clinical application. Topics include cutting-edge molecule formats such as bispecific antibodies, next-generation antibody-drug conjugates (ADCs), and the use of artificial intelligence and machine learning for molecular prediction and optimization. Alternative protein scaffolds, hard-to-target antigens, and novel approaches in immuno-oncology also play a central role.

Participants represent a diverse range of organizations across biotechnology, pharmaceutical research, platform technologies, and academia. Presentations highlight the latest advances in screening platforms, targeting strategies, clinical development, and computational modeling. A particular emphasis is placed on clinical translation, with exclusive insights into ongoing studies and real-world case examples.

Antibody Engineering & Therapeutics Asia is more than a networking event – it is a forward-looking forum at the intersection of science and business, focused on the future of antibody therapeutics. The conference attracts leading scientists, R&D teams, business developers, technology providers, and industry decision-makers, especially from the fields of oncology, immunology, diagnostics, and drug delivery.

As part of a global event series with additional stops in North America and Europe, the Asia edition is tailored specifically to the needs of the regional market. Japan’s strong research ecosystem makes it an ideal location, and Kyoto stands out with its unique blend of cultural heritage and technological excellence. The Westin Miyako Kyoto not only offers an impressive setting, but also benefits from excellent transport links, with convenient access to international airports, train stations, and major attractions.

The Antibody Engineering & Therapeutics Asia will take place on 3 days from Monday, 20. October to Wednesday, 22. October 2025 in Kyoto.